Type-specific antibodies to purified streptococcal M proteins from potentially rheumatogenic M-types in patients with rheumatic fever and rheumatic heart disease

Journal of Medical Microbiology

Volumn 45, Issue 6, 1996, Pages 483-489

  Thakur, A ^a,b   Singhal, S ^a   Prakash, K ^a  

^a Lady Hardinge's Medical College   (India)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; M PROTEIN; VACCINE;

ARTICLE; CASE REPORT; HUMAN; INDIA; PRIORITY JOURNAL; PROTEIN PURIFICATION; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; STREPTOCOCCUS;

EID: 0029972202     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-45-6-483     Document Type: Article

References (23)

1. Padmavati S, Gupta V, Prakash K, Sharma KB. Penicillin for rheumatic fever prophylaxis. 3-weekly or 4-weekly schedule? J Assoc Physicians India 1987; 35: 753-755.
2. Siegel AC, Johnson EE, Stollerman G. Controlled studies of streptococcal pharyngitis in a pediatric population. 1. factors related to the attack rate of rheumatic fever. N Engl J Med 1963: 268.
3. Wannamaker LW. The chain that links the heart to the throat. Circulation 1973; 48: 9-18.
4. Committee on Rheumatic fever and Bacterial Endocarditis, American Heart Association. Report Prevention of rheumatic fever. Circulation Suppl 1977; 55: S1-S4.
5. Stollerman GH. Laboratory diagnostic procedure. In: Cohen A S (ed) The rheumatic diseases. Boston, Little, Brown and Company. 1967.
6. Fuller AT. The formamide method for the extraction of polysaccharides from haemolytic streptococci. Br J Exp Pathol 1938; 19: 130-139.
7. Rotta J, Krause RM, Lancefield RC, Everly W, Lackland H. New approaches for the laboratory recognition of M types of Group A streptococci. J Exp Med 1971; 134: 1298-1315.
8. Manjula BN, Fischetti VA. Studies on group A streptococeal M proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules. J Immunol 1980; 124: 261-267.
9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
10. Maizel JV. Polyacrylamide gel electrophoresis of viral proteins, In: Maramorosh K, Kaprowski H (eds) Methods in virology, vol. 5. New York, Academic Press. 1971: 179-246.
11. Bisno AL, Berries X, Quesney, F, Manroe DM, Dale JB, Beachey EH. Type-specific antibodies to structurally defined fragments of streptococcal M-proteins in patients with acute rheumatic fever. Infect Immun 1982; 38: 573-579.
12. Lancefield RC. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med 1959; 110: 271-292.
13. Cunningham MW, Beachey EH. Peptic digestion of streptococeal M protein 1. Effect of digestion at suboptimal pH upon the biological and immunochemical properties of purified M protein extracts. Infect Immun 1974; 9: 244-248.
14. Bisno AL, Pearce IA, Stollerman GH. Streptococeal infections that fail to cause recurrence of rheumatic fever. J Infect Dis 1977; 136: 278-285.
15. Bisno AL, Pearce IA, Wall HP, Moody MD, Stollerman GH. Contrasting epidemiology of acute rheumatic fever and acute glomeruloneophritis. Nature of the antecedent streptococcal infection. N Engl J Med 1970; 283: 561-565.
16. Bloomfield AL, Rantz LA. An outbreak of streptococcal sore throat in an army camp: clinical and epidemiological observations. JAMA 1943; 121: 315-319.
17. Kuttner AG, Krumwiede E. Observation of the effect of streptococcal upper respiratory infections on the rheumatic children: a three-year study. J Clin Invest 1941; 20: 273-287.
18. Potter EV, Svartman M, Poon-King T, Earle DP. The families of patients with acute rheumatic fever or glomerulonephritis in Trinidad. Am J Epidemiol 1977; 106: 130-138.
19. Stollerman GH. The relative rheumatogenicity of strain of group A streptococci. Mod Concepts Cardiovasc Dis 1975; 44: 34-40.
20. Widdowson JP, Maxted WR, Notley CM, Pinney AM. The antibody responses in man to infection with different serotypes of group-A streptococci. J Med Microbiol 1974; 7: 483-496.
21. Beachey EH, Seyer JM, Dale JB, Simpson WA, Kang AH. Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M-protein. Nature 1981; 292: 457-459.
22. Beachey EH, Seyer JM, Kang AH. Primary structure of protective antigens of type 24 streptococcal M-protein. J Biol Chem 1980; 255: 6284-6289.
23. Bisno AL. The concept of rheumatogenic and nonrheumatogenic group A streptococci. In: Read S E, Zabriskie Z B (eds) Streptococcal diseases and the immune response. New York, Academic Press. 1980; 789-803.